Your browser doesn't support javascript.
loading
De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma.
Ma, Si-Cong; Zhu, Hong-Bo; Wang, Jian; Zhang, Yan-Pei; Guo, Xue-Jun; Long, Li-Li; Guo, Ze-Qin; Wu, De-Hua; Dong, Zhong-Yi; Bai, Xue.
Afiliación
  • Ma SC; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhu HB; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang J; Department of Oncology, The First Affiliated Hospital of University of South China, Hengyang, China.
  • Zhang YP; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Guo XJ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Long LL; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Guo ZQ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Bai X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Front Oncol ; 11: 666145, 2021.
Article en En | MEDLINE | ID: mdl-34221982

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza